J Biomed Pharma Res
Both drugs changed how doctors and patients think about treating obesity
Dual- and triple action approaches which simultaneously target multiple pathways, for example, GLP1R/GIP (tirzepatide), GLP1R/GIP/glucagon (retatrutide) or amylin/GLP1R (CagriSemra) appear more potent and may push weight reduction to the mid-20% range and possibly beyond, while oral options seek to deliver levels of efficacy seen with injectables
Testing Ferritin Levels to Rule Out Iron Overload as Cause of Inflammation Testing Instances of iron deficiency can occur due to factors such as chronic disease, heavy menstrual periods, intestinal bleeding, and blood disorders
Longenecker JZ, Petrosino JM, Martens CR, Hinger SA, Royer CJ, Dorn LE, Branch DA, Serrano J, Stanford KI, Kyriazis GA, Baskin KK, Accornero F
Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences, 17(10), 985-7